Healthcare | April 17, 2026
Experts push for preventive, equitable haemophilia care at IHC X Summit
The national platform brought together healthcare professionals, patient advocates, and stakeholders
The national platform brought together healthcare professionals, patient advocates, and stakeholders
The conference aims to bring various stakeholders and experts in the field of healthcare and digital solutions for ensuring ‘universal access to affordable and quality healthcare’
A major push to sharpen the future of cancer treatment is underway
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
The FDA approval makes PD-L1 IHC 22C3 pharmDx the only companion diagnostic approved to detect tumors expressing PD-L1 in esophageal or GEJ carcinoma patients for KEYTRUDA treatmen
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
This approval represents the seventh FDA-approved companion diagnostic indication for PD-L1 IHC 22C3 pharmDx with KEYTRUDA
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
The receipt of this permission paves way for the marketing of Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) in India
While the trial fell short of demonstrating a statistically significant PFS benefit compared to chemotherapy, early data suggest a potential overall survival advantage
Subscribe To Our Newsletter & Stay Updated
